LongGMABAug 2026
Genmab A/S
Genmab is a vertically integrated pharmaceutical company specialising in antibody therapeutics for cancer. Better-than-expected second-quarter results were supported by continued…
GMAB
Which hedge funds are long GMAB?
1 published idea on Genmab A/S across 1 fund — 1 long and 0 short.
Genmab A/S hedge fund investment theses
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Genmab A/S: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.